Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters

Proceedings of the National Academy of Sciences of the United States of America

Volumn 98, Issue 26, 2001, Pages 15161-15166

  Dybul, Mark ^a   Chun, Tae Wook ^a   Yoder, Christian ^a   Hidalgo, Bertha ^a   Belson, Michael ^a   Hertogs, Kurt ^b   Larder, Brendan ^b   Dewar, Robin L ^c   Fox, Cecil H ^d   Hallahan, Claire W ^a   Justement, J Shawn ^a   Migueles, Stephen A ^a   Metcalf, Julia A ^a   Davey, Richard T ^a   Daucher, Marybeth ^a   Pandya, Punita ^a   Baseler, Michael ^c   Ward, Douglas J ^e   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Virco BVBA   (Belgium)

^c SAIC FREDERICK INC   (United States)

^d Molecular Histology Laboratories   (United States)

^e Dupont Circle Physicians Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHOLESTEROL; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; TRIACYLGLYCEROL; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG COST; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INTERMITTENT THERAPY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; VIREMIA; VIRUS REPLICATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; LYMPH NODES; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PILOT PROJECTS; RNA, VIRAL;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0035910032     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.261568398     Document Type: Article

References (36)